TEVOGEN BIO HOLDINGS INC. - COMMON STOCK
1.4700
07-2月-25 15:45:00
15 分の遅延
株式
+0.0500
+3.52%
本日の幅
1.3900 - 1.5000
ISIN
N/A
ソース
NASDAQ
-
11 4 2024 07:05:00 提供 Nasdaq GlobeNewswire
-
Tevogen Bio Appoints Tapan V Shah as Head of Investor Relations and Corporate Development
03 4 2024 07:05:00 提供 Nasdaq GlobeNewswire
-
Tevogen Bio Reports Series A-1 Preferred Stock Investment at $10 Conversion Price
28 3 2024 07:05:00 提供 Nasdaq GlobeNewswire